切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2018, Vol. 07 ›› Issue (06) : 557 -561. doi: 10.3877/cma.j.issn.2095-3224.2018.06.010

所属专题: 文献

论著

符合Amsterdam标准的结肠肿瘤患者异时结直肠肿瘤发病风险研究
周欣1, 杨柳1, 张晓梅2, 李东正1, 朱明2, 周建农1, 陈森清2,()   
  1. 1. 210009 南京医科大学附属江苏省肿瘤医院普外科
    2. 210009 南京,江苏省肿瘤防治研究所遗传与分子生物学研究室
  • 收稿日期:2017-12-21 出版日期:2018-12-25
  • 通信作者: 陈森清
  • 基金资助:
    江苏省医学重点人才项目(No.RC2011092)

Risk of metachronous colorectal carcinoma and adenoma after colectomy for colon neoplasma in patients from families meeting the Amsterdam Criteria

Xin Zhou1, Liu Yang1, Xiaomei Zhang2, Dongzheng Li1, Ming Zhu2, Jiannong Zhou1, Senqing Chen2,()   

  1. 1. Department of General Surgery, the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University, Nanjing 210009, China
    2. Laboratory of Genetics and Molecular Biology, Jiangsu Institute of Cancer Research, the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University, Nanjing 210009, China
  • Received:2017-12-21 Published:2018-12-25
  • Corresponding author: Senqing Chen
  • About author:
    Corresponding author: Chen Senqing, Email:
引用本文:

周欣, 杨柳, 张晓梅, 李东正, 朱明, 周建农, 陈森清. 符合Amsterdam标准的结肠肿瘤患者异时结直肠肿瘤发病风险研究[J/OL]. 中华结直肠疾病电子杂志, 2018, 07(06): 557-561.

Xin Zhou, Liu Yang, Xiaomei Zhang, Dongzheng Li, Ming Zhu, Jiannong Zhou, Senqing Chen. Risk of metachronous colorectal carcinoma and adenoma after colectomy for colon neoplasma in patients from families meeting the Amsterdam Criteria[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2018, 07(06): 557-561.

目的

探讨符合Amsterdam标准的结肠肿瘤患者术后异时结直肠癌及高危腺瘤的发病风险及对生存的影响。

方法

回顾分析南京医科大学附属江苏省肿瘤医院收治的34例符合Amsterdam标准的结肠肿瘤患者术后生存与异时结直肠肿瘤发病的随访资料。

结果

6例患者接受了结肠全切除治疗,中位随访122个月,无异时结直肠肿瘤发生。28例患者接受了结肠部分切除治疗,中位随访82个月,10例发生了异时结直肠癌,1例发生了需要手术切除的异时结肠腺瘤。结肠部分切除组5年和10年累计异时结直肠肿瘤发病风险分别为24.1%和48.2%,与结肠全切除组相比差异具有统计学意义(P=0.047)。全组总体5年和10年生存率分别为100%和85.6%。结肠部分切除组与结肠全切除组总体生存率差异无统计学意义(P=0.306)。发生异时结直肠肿瘤的患者与没有发生异时结直肠肿瘤的患者相比,总体生存率差异无统计学意义(P=0.901)。结肠部分切除后患者性别、年龄、既往结直肠癌手术史、肿瘤部位、分化程度和分期与异时结直肠肿瘤的发病风险均无显著相关关系。

结论

符合Amsterdam标准的结肠肿瘤患者术后发生异时结直肠肿瘤的风险相当高,与结肠部分切除相比,结肠全切除治疗有助于预防异时结直肠肿瘤,但不能显著改善总体生存率。

Objective

To investigate the risk of metachronous colorectal cancer and high risk colorectal adenoma after colectomy for colon neoplasma and its impact on survival in a cohort of patients of families fulfilling the Amsterdam criteria.

Methods

Thirty-four patients of families fulfilling the Amsterdam criteria who underwent colectomy in the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University for colon neoplasm was identified from a single-institution hereditary colorectal cancer database. The demographics, clinicopathological characteristics of the index CRC, and the follow-up data about survival and metachronous colorectal neoplasma were analyzed.

Results

No metachronous colorectal neoplasm occurred in six patients who underwent total or subtotal colectomy during a median follow-up of 122 months. Of twenty-eight patients who underwent segmental colectomy, ten developed metachronous colorectal cancer, and one adenoma that need abdominal resection during a median follow-up of eighty-two months. The cumulative risk of metachronous colorectal neoplasma was 24.1% at 5 years and 48.2% at 10 years in segmental colectomy patients, which was significantly different than that in total colectomy patients (P=0.047). The overall cumulative survival was 100% at 5 years and 85.6% at 10 years. No significant difference in overall survival was observed between segmental colectomy and total colectomy (P=0.306), or between metachronous colorectal neoplasma positive and free patients (P=0.901). Patient gender, age, past history of colorectal surgery for colorectal cancer, tumor site, differentiation or stage were not risk factors for metachronous colorectal neoplasma after segmental colectomy.

Conclusions

Patients of families meeting Amsterdam criteria carry a high risk of metachronous colorectal carcinoma and high risk adenoma. Total colectomy, compared with segmental colectomy, can reduce metachronous colorectal tumor risk, however dose not significantly improve overall survival.

表1 发生异时结直肠肿瘤患者的临床病理特征
表2 结肠肿瘤临床病理特征与异时结直肠肿瘤发病风险的Cox回归分析结果
[1]
Herzig DO, Buie WD, Weiser MR, et al. Clinical practice guidelines for the surgical treatment of patients with lynch syndrome [J].Dis Colon Rectum, 2017, 60(2): 137-143.
[2]
李晓芬, 袁瑛, 张苏展. 中国人遗传性大肠癌综合征的特征及诊疗规范[J].中国癌症杂志, 2015, 25(11): 841-848.
[3]
Vasen HF, Mecklin JP, Khan PM, et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) [J].Dis Colon Rectum, 1991, 34(5): 424-425.
[4]
Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC [J].Gastroenterology, 1999, 116(6): 1453-1456.
[5]
Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X [J]. JAMA,2005,293(16):1979-1985.
[6]
Kalady MF, McGannon E, Vogel JD, et al. Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting amsterdam criteria [J].Ann Surg, 2010, 252(3):507-511.
[7]
张渊智, 张志芳, 张帆, 等. 中国人遗传性非息肉病性结直肠癌常见临床表型特征与肠外肿瘤谱分析[J].胃肠病学和肝病学杂志, 2011, 20(6): 513-518.
[8]
刘善润, 王振军, 赵博, 等. 遗传性非息肉病性结直肠癌患者的临床特点及hMSH2与hMLH1种系突变的筛查[J].中华医学杂志, 2004, 84(9): 714-717.
[9]
蔡三军, 蔡崎, 孙孟红, 等. 遗传性非息肉病性结直肠癌家系及临床病理特征分析[J].中华消化杂志, 2004, 24(2): 90-93.
[10]
Cirillo L, Urso ED, Parrinello G, et al. High risk of rectal cancer and of metachronous colorectal cancer in probands of families fulfilling the Amsterdam criteria [J].Ann Surg, 2013, 257(5): 900-904.
[11]
You YN, Chua HK, Nelson H, et al. Segmental vs. extended colectomy: measurable differences in morbidity, function, and quality of life [J].Dis Colon Rectum, 2008, 51(7): 1036-1043.
[12]
Haanstra JF, de Vos Tot Nederveen Cappel WH, Gopie JP, et al. Quality of life after surgery for colon cancer in patients with lynch syndrome: partialversus subtotal colectomy [J]. Dis Colon Rectum, 2012, 55(6): 653-659.
[1] 李怡泉, 谢宇斌, 胡宏, 张燕茹, 陈图锋. 基于生物信息学分析HDAC8在结肠癌中的临床意义及其与免疫浸润的关系[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 275-281.
[2] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[3] 周丽, 林巧. 腹腔镜TME与开腹手术治疗原发性直肠癌对患者近远期疗效及生存率的影响比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 544-546.
[4] 崔宏帅, 冯丽明, 东维玲, 韩博. 腹腔镜右半结肠癌D3根治术+IGLN清扫术治疗局部进展期结肠肝曲癌的临床效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 566-569.
[5] 丁志翔, 于鹏, 段绍斌. 血浆BRAF基因检测对腹腔镜右半结肠癌D3根治术中行幽门淋巴结清扫的指导价值[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 570-573.
[6] 王维花, 王楠, 乔庆, 罗红. 完全腹腔镜右半结肠癌切除术两种腔内消化道重建方案对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 574-577.
[7] 李晓鸥, 杨鹤鸣, 王国栋, 林海冠, 杨建武. 不同入路腹腔镜左半结肠癌根治术治疗效果对比[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 377-380.
[8] 孙龙凤, 侯高峰, 王幼黎, 刘磊. 腹腔镜下右半结肠癌D3根治术中SMA或SMV入路的选择[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 438-441.
[9] 宋华传, 季鹏, 姚焕章, 王永帅, 张珅瑜, 宋瑞鹏, 王继洲. 腹腔镜肝切除术联合微波消融治疗多发性结直肠癌肝转移[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 222-226.
[10] 何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687.
[11] 关国欣, 罗福文. 结肠癌合并急性梗阻的个性化处理[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 459-463.
[12] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
[13] 任佳琪, 刁德昌, 何自衍, 张雪阳, 唐新, 李文娟, 李洪明, 卢新泉, 易小江. 网膜融合线导向的脾曲游离技术在左半结肠癌根治术中的应用[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 362-367.
[14] 朱军, 宋家伟, 乔一桓, 郭雅婕, 刘帅, 姜玉, 李纪鹏. M2型巨噬细胞特征基因与结肠癌免疫微环境研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 303-311.
[15] 靳英, 付小霞, 陈美茹, 袁璐, 郝力瑶. CD147调控MAPK信号通路对结肠癌细胞增殖和凋亡的影响及机制研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 474-480.
阅读次数
全文


摘要